VERU INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
VERU INC. (VERU) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 185.69 thousand shares for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2026-08-10
- VERU INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2026-06-30 was 13.95K shares.
- VERU INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2026-03-31 was 38.17K shares, a 69.15% decline year-over-year.
- VERU INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-12-31 was 133.57K shares, a 75.93% decline year-over-year.
- VERU INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-06-30 was -600.40K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month |
|---|---|---|---|
| 2026-06-30 | 13.95K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-10 | 52.12K shares derived: sum of 2 quarters · filed 2026-08-10 | 185.69K shares 10-Q · filed 2026-08-10 |
| 2026-03-31 | 38.17K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-13 | 171.74K shares 10-Q · filed 2026-05-13 | |
| 2025-12-31 | 133.57K shares 10-Q · filed 2026-02-11 | ||
| 2025-06-30 | -600.40K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-12 | -476.69K shares derived: sum of 2 quarters · filed 2025-08-12 | 78.17K shares 10-Q · filed 2025-08-12 |
| 2025-03-31 | 123.71K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-08 | 678.58K shares 10-Q · filed 2025-05-08 | |
| 2024-12-31 | 554.87K shares 10-Q · filed 2025-02-13 | ||
| 2024-06-30 | 1.05M shares 10-Q · filed 2024-08-08 | ||
| 2012-06-30 | 2.50K shares 10-Q · filed 2013-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |